why choose us

First received: March 08, 2023

Clinical Trial: Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Von Willebrand Diseases

Study Type: INTERVENTIONAL


Official Title: A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of VGA039 Following IV or SC Administration of Single Ascending Doses in Healthy Adults and Subcutaneous Adult Patients With Von Will

Brief Summary: This is a multi-center, Phase 1a study to assess the safety, tolerability, PK, and PD of VGA039 following single IV or SC dose administration in healthy subjects and Von Willebrand disease patients.

Read more